Amy E. McKee - 24 Jun 2024 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Director
Signature
/s/ Alane P. Barnes, by power of attorney
Issuer symbol
BCRX
Transactions as of
24 Jun 2024
Net transactions value
-$54,352
Form type
4
Filing time
25 Jun 2024, 16:39:56 UTC
Previous filing
14 Jun 2024
Next filing
16 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Sale $54,352 -8,600 -24% $6.32 27,831 24 Jun 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold with the sole purpose of generating sufficient proceeds to cover the tax liability incurred in connection with the vesting of 16,745 Restricted Stock Units on June 13, 2024.
F2 The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $6.25 to $6.42. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.